{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:15:21Z","timestamp":1791396921325,"version":"4.3.3"},"reference-count":282,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a dosage-sensitive kinase with critical roles in the neuron-astrocyte axis. During brain development, DYRK1A ensures the proper number of differentiated neurons and astrocytes. In neurons, this DYRK1A regulates neuronal morphogenesis and synaptic transmission. However, its functions in astrocytes are not yet well defined, with limited evidence indicating roles in astrocyte reactivity and excitotoxicity. Due to trisomy 21, DYRK1A is overexpressed in individuals with Down syndrome (DS). This imbalance directly contributes to neuronal death and likely astrocyte pathology, accelerating the onset of Alzheimer\u2019s disease (AD) in this population. Notably, DYRK1A overexpression also correlates with neurodegeneration and AD progression in elderly euploid adults. This correlation positions DYRK1A as a potential bridge between DS and AD, mechanistically connecting gene overdosage and neuropathology in both conditions. However, research on DYRK1A pathophysiology has primarily centered on neurons, leaving astrocytes largely understudied. Considering the vital neuroprotective functions of astrocytes, broadening DYRK1A research to encompass these cells presents an opportunity to uncover novel mechanisms contributing to the neurodegenerative process in AD. In this review, we highlight the physiology and pathology of DYRK1A in the neuron\u2013astrocyte axis, analyzing its roles in neurons and positing hypothetical functions in astrocytes, with particular emphasis on the contribution of DYRK1A\u2019s cell-specific overexpression to neurodegeneration and AD progression.<\/jats:p>","DOI":"10.3389\/fnins.2025.1626062","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:14:27Z","timestamp":1760933667000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["DYRK1A in the physiology and pathology of the neuron-astrocyte axis"],"prefix":"10.3389","volume":"19","author":[{"given":"Pablo","family":"Cisternas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Ashfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Zartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1021\/bi700251n","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro.","volume":"46","author":"Adayev","year":"2007","journal-title":"Biochemistry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.bbrc.2006.10.169","article-title":"MNB\/DYRK1A phosphorylation regulates the interactions of synaptojanin 1 with endocytic accessory proteins.","volume":"351","author":"Adayev","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/acel.12054","article-title":"Ca(2+) -dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid \u03b2-treated astrocytes and in a model of Alzheimer\u2019s disease.","volume":"12","author":"Alberdi","year":"2013","journal-title":"Aging Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1038\/s41380-022-01486-x","article-title":"Astrocytes derived from ASD individuals alter behavior and destabilize neuronal activity through aberrant Ca2+ signaling.","volume":"27","author":"Allen","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1093\/hmg\/10.18.1915","article-title":"Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down\u2019s syndrome.","volume":"10","author":"Altafaj","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1277537","DOI":"10.3389\/fcell.2023.1277537","article-title":"Insights from the protein interaction Universe of the multifunctional \u201cGoldilocks\u201d kinase DYRK1A.","volume":"11","author":"Ananthapadmanabhan","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/ph16030443","article-title":"Development of novel fluorinated polyphenols as selective inhibitors of DYRK1A\/B kinase for treatment of neuroinflammatory diseases including Parkinson\u2019s disease.","volume":"16","author":"Araldi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1096\/fj.10-165837","article-title":"DYRK family of protein kinases: Evolutionary relationships, biochemical properties, and functional roles.","volume":"25","author":"Aranda","year":"2011","journal-title":"FASEB J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1007\/s12035-017-0818-6","article-title":"Down syndrome iPSC-Derived astrocytes impair neuronal synaptogenesis and the mTOR pathway in vitro.","volume":"55","author":"Araujo","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pharmthera.2018.09.010","article-title":"DYRK1A and cognition: A lifelong relationship.","volume":"194","author":"Arbones","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","article-title":"The role of astroglia in Alzheimer\u2019s disease: Pathophysiology and clinical implications.","volume":"18","author":"Arranz","year":"2019","journal-title":"Lancet Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00018-015-2032-x","article-title":"Identification of DYRK1B as a substrate of ERK1\/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome.","volume":"73","author":"Ashford","year":"2015","journal-title":"Cell Mol. Life Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"14599","DOI":"10.1074\/jbc.M113.466235","article-title":"Loss of calcium\/calmodulin-dependent protein kinase II activity in cortical astrocytes decreases glutamate uptake and induces neurotoxic release of ATP.","volume":"288","author":"Ashpole","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3390\/genes12111833","article-title":"Dyrk1a from gene function in development and physiology to dosage correction across life span in down syndrome.","volume":"12","author":"Atas-Ozcan","year":"2021","journal-title":"Genes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2164-11-25","article-title":"High-content siRNA screening of the kinome identifies kinases involved in Alzheimer\u2019s disease-related tau hyperphosphorylation.","volume":"11","author":"Azorsa","year":"2010","journal-title":"BMC Genom."},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40478-021-01152-3","article-title":"Space-occupying brain lesions, trauma-related tau astrogliopathy, and ARTAG: A report of two cases and a literature review.","volume":"9","author":"Bachstetter","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s11357-022-00708-y","article-title":"Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer\u2019s disease.","volume":"45","author":"Ballesteros-\u00c1lvarez","year":"2023","journal-title":"Geroscience"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1289","DOI":"10.1038\/cddis.2014.253","article-title":"DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson\u2019s disease.","volume":"5","author":"Barallobre","year":"2014","journal-title":"Cell Death Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1742-4658.2010.07956.x","article-title":"Activation, regulation, and inhibition of DYRK1A.","volume":"278","author":"Becker","year":"2011","journal-title":"FEBS J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"104168","DOI":"10.1016\/j.ebiom.2022.104168","article-title":"DYRK1A: A promising protein kinase target for cardiomyocyte cycling and cardiac repair through epigenetic modifications.","volume":"82","author":"Bei","year":"2022","journal-title":"EBioMedicine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1523\/JNEUROSCI.3516-14.2015","article-title":"The JAK\/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer\u2019s and Huntington\u2019s diseases.","volume":"35","author":"Ben Haim","year":"2015","journal-title":"J. Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.4065\/80.10.1326","article-title":"Neuron-astrocyte interactions: Partnership for normal function and disease in the central nervous system.","volume":"80","author":"Benarroch","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2005.02.004","article-title":"Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+\/- mouse.","volume":"20","author":"Benavides-Piccione","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nn1246","article-title":"Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate.","volume":"7","author":"Bezzi","year":"2004","journal-title":"Nat. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1111\/febs.16065","article-title":"Long-term plasticity in the hippocampus: Maintaining within and \u2018tagging\u2019 between synapses.","volume":"289","author":"Bin Ibrahim","year":"2022","journal-title":"FEBS J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e3002712","DOI":"10.1371\/journal.pbio.3002712","article-title":"Activity-induced reactivity of astrocytes impairs cognition.","volume":"22","author":"Bohmbach","year":"2024","journal-title":"PLoS Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s004010051077","article-title":"Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.","volume":"98","author":"Botez","year":"1999","journal-title":"Acta Neuropathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1009777","DOI":"10.1371\/journal.pgen.1009777","article-title":"Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome.","volume":"17","author":"Brault","year":"2021","journal-title":"PLoS Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e12914","DOI":"10.1111\/bpa.12914","article-title":"Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.","volume":"31","author":"Briel","year":"2021","journal-title":"Brain Pathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/cbin.10694","article-title":"Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: Hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.","volume":"40","author":"\u00c7a\u011flayan","year":"2016","journal-title":"Cell Biol. Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1393165","DOI":"10.3389\/fnins.2024.1393165","article-title":"Regulated exocytosis from astrocytes: A matter of vesicles?","volume":"18","author":"Cal\u00ec","year":"2024","journal-title":"Front. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e108341","DOI":"10.15252\/embj.2021108341","article-title":"The ion-coupling mechanism of human excitatory amino acid transporters.","volume":"41","author":"Canul-Tec","year":"2022","journal-title":"EMBO J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00259-018-4217-7","article-title":"Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer\u2019s disease.","volume":"46","author":"Carter","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"B34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2967\/jnumed.110.087031","article-title":"Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: A multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.","volume":"53","author":"Carter","year":"2012","journal-title":"J. Nucl. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2016.08.022","article-title":"Association of DYRK1A polymorphisms with sporadic Parkinson\u2019s disease in Chinese Han population.","volume":"632","author":"Cen","year":"2016","journal-title":"Neurosci. Lett."},{"key":"B36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuroscience.2016.05.043","article-title":"The complex STATes of astrocyte reactivity: How are they controlled by the JAK-STAT3 pathway?","volume":"330","author":"Ceyz\u00e9riat","year":"2016","journal-title":"Neuroscience"},{"key":"B37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40478-018-0606-1","article-title":"Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer\u2019s disease.","volume":"6","author":"Ceyz\u00e9riat","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/jnc.13913","article-title":"Constitutive regulation of the glutamate\/aspartate transporter EAAT1 by calcium-calmodulin-dependent protein kinase II.","volume":"140","author":"Chawla","year":"2017","journal-title":"J. Neurochem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1038\/ncomms5246","article-title":"Activity-dependent facilitation of Synaptojanin and synaptic vesicle recycling by the Minibrain kinase.","volume":"5","author":"Chen","year":"2014","journal-title":"Nat. Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1038\/ncomms5430","article-title":"Role of astroglia in Down\u2019s syndrome revealed by patient-derived human-induced pluripotent stem cells.","volume":"5","author":"Chen","year":"2014","journal-title":"Nat. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"17597","DOI":"10.1074\/jbc.M111101200","article-title":"Dynamin is a minibrain kinase\/dual specificity Yak1-related kinase 1A substrate.","volume":"277","author":"Chen-Hwang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fnins.2017.00217","article-title":"Amyloid \u03b2-Exposed human astrocytes overproduce phospho-tau and overrelease it within exosomes, effects suppressed by calcilytic NPS 2143-further implications for Alzheimer\u2019s therapy.","volume":"11","author":"Chiarini","year":"2017","journal-title":"Front. Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fncel.2019.00399","article-title":"Upregulated expression of MicroRNA-204-5p leads to the death of dopaminergic cells by targeting DYRK1A-Mediated apoptotic signaling cascade.","volume":"13","author":"Chiu","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"dmm037044","DOI":"10.1242\/dmm.037044","article-title":"Vascular defects of DYRK1A knockouts are ameliorated by modulating calcium signaling in zebrafish.","volume":"12","author":"Cho","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"B45","doi-asserted-by":"publisher","first-page":"116233","DOI":"10.1016\/j.bcp.2024.116233","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A promotes the inclusion of amyloid precursor protein exon 7.","volume":"224","author":"Chu","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/s41593-020-00735-y","article-title":"Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer\u2019s disease via H2O2- production.","volume":"23","author":"Chun","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/1533317518761093","article-title":"Aging with down syndrome: The dual diagnosis: Alzheimer\u2019s disease and down syndrome.","volume":"33","author":"Cipriani","year":"2018","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"B48","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.1007\/s12035-015-9609-0","article-title":"Gestational hypothyroxinemia affects glutamatergic synaptic protein distribution and neuronal plasticity through neuron-astrocyte interplay.","volume":"53","author":"Cisternas","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"fcac235","DOI":"10.1093\/braincomms\/fcac235","article-title":"The reduction of astrocytic tau prevents amyloid-\u03b2-induced synaptotoxicity.","volume":"4","author":"Cisternas","year":"2022","journal-title":"Brain Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e13233","DOI":"10.1111\/acel.13233","article-title":"Vascular amyloid accumulation alters the gabaergic synapse and induces hyperactivity in a model of cerebral amyloid angiopathy.","volume":"19","author":"Cisternas","year":"2020","journal-title":"Aging Cell."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1038\/s41598-020-59757-y","article-title":"A Munc18-1 mutant mimicking phosphorylation by Down Syndrome-related kinase Dyrk1a supports normal synaptic transmission and promotes recovery after intense activity.","volume":"10","author":"Classen","year":"2020","journal-title":"Sci. Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"16102","DOI":"10.1523\/JNEUROSCI.2491-10.2010","article-title":"Glial fibrillary tangles and JAK\/STAT-mediated glial and neuronal cell death in a Drosophila model of glial tauopathy.","volume":"30","author":"Colodner","year":"2010","journal-title":"J. Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neurobiolaging.2004.01.006","article-title":"Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo.","volume":"25","author":"Craft","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"B54","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1523\/JNEUROSCI.3861-05.2006","article-title":"Impaired glutamate transport in a mouse model of tau pathology in astrocytes.","volume":"26","author":"Dabir","year":"2006","journal-title":"J. Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s0002-9440(10)63106-9","article-title":"Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology.","volume":"164","author":"Dabir","year":"2004","journal-title":"Am. J. Pathol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/mp.2016.253","article-title":"Autism-associated Dyrk1a truncation mutants impair neuronal dendritic and spine growth and interfere with postnatal cortical development.","volume":"23","author":"Dang","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12974-021-02117-y","article-title":"Pharmacological ablation of astrocytes reduces A\u03b2 degradation and synaptic connectivity in an ex vivo model of Alzheimer\u2019s disease.","volume":"18","author":"Davis","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"B58","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-023-06502-w","article-title":"Specialized astrocytes mediate glutamatergic gliotransmission in the CNS.","volume":"622","author":"de Ceglia","year":"2023","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/mnfr.201300325","article-title":"Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.","volume":"58","author":"De la Torre","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","article-title":"Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down\u2019s syndrome (TESDAD): A double-blind, randomised, placebo-controlled, phase 2 trial.","volume":"15","author":"de la Torre","year":"2016","journal-title":"Lancet Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"9355","DOI":"10.3390\/ijms23169355","article-title":"The omnipresence of DYRK1A in human diseases.","volume":"23","author":"Deboever","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1038\/ncomms6422","article-title":"Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer\u2019s disease mouse model.","volume":"5","author":"Delekate","year":"2014","journal-title":"Nat. Commun."},{"key":"B63","doi-asserted-by":"publisher","first-page":"10674","DOI":"10.1523\/JNEUROSCI.2001-07.2007","article-title":"Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus.","volume":"27","author":"Ding","year":"2007","journal-title":"J. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.4103\/1673-5374.306064","article-title":"Astrocytes: A double-edged sword in neurodegenerative diseases.","volume":"16","author":"Ding","year":"2021","journal-title":"Neural Regen. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e1001985","DOI":"10.1371\/journal.pbio.1001985","article-title":"PI3K signaling and Stat92E converge to modulate glial responsiveness to axonal injury.","volume":"12","author":"Doherty","year":"2014","journal-title":"PLoS Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1097\/NEN.0b013e31827733c8","article-title":"Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients.","volume":"71","author":"Dowjat","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3233\/JAD-190475","article-title":"Abnormalities of DYRK1A-Cytoskeleton complexes in the blood cells as potential biomarkers of Alzheimer\u2019s disease.","volume":"72","author":"Dowjat","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fnbeh.2016.00104","article-title":"DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in down syndrome.","volume":"10","author":"Duchon","year":"2016","journal-title":"Front. Behav. Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gene.10150","article-title":"GAL4 system in Drosophila: A fly geneticist\u2019s Swiss army knife.","volume":"34","author":"Duffy","year":"2002","journal-title":"Genesis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions.","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e152012","DOI":"10.1172\/jci.insight.152012","article-title":"Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction.","volume":"7","author":"Ezerskiy","year":"2022","journal-title":"JCI Insight"},{"key":"B72","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neulet.2016.04.014","article-title":"The GBA, DYRK1A and MS4A6A polymorphisms influence the age at onset of Chinese Parkinson patients.","volume":"621","author":"Fan","year":"2016","journal-title":"Neurosci. Lett."},{"key":"B73","first-page":"1388","article-title":"Widespread cytoskeletal pathology characterizes corticobasal degeneration.","volume":"146","author":"Feany","year":"1995","journal-title":"Am. J. Pathol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.seizure.2011.01.010","article-title":"Overexpression of \u03bc-calpain in the anterior temporal neocortex of patients with intractable epilepsy correlates with clinicopathological characteristics.","volume":"20","author":"Feng","year":"2011","journal-title":"Seizure"},{"key":"B75","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1523\/JNEUROSCI.2551-21.2022","article-title":"DYRK1A regulates the bidirectional axonal transport of APP in human-derived neurons.","volume":"42","author":"Fernandez Bessone","year":"2022","journal-title":"J. Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.nbd.2005.03.020","article-title":"Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.","volume":"20","author":"Ferrer","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"B77","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/bpa.12593","article-title":"Aging-related tau astrogliopathy (ARTAG): Not only tau phosphorylation in astrocytes.","volume":"28","author":"Ferrer","year":"2018","journal-title":"Brain Pathol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/NEN.0000000000000180","article-title":"Familial behavioral variant frontotemporal dementia associated with astrocyte-predominant tauopathy.","volume":"74","author":"Ferrer","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/NEN.0000000000000030","article-title":"Glial and neuronal tau pathology in tauopathies: Characterization of disease-specific phenotypes and tau pathology progression.","volume":"73","author":"Ferrer","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s40478-023-01655-1","article-title":"Determinants of astrocytic pathology in stem cell models of primary tauopathies.","volume":"11","author":"Fiock","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"645233","DOI":"10.3389\/fncel.2021.645233","article-title":"Astrocytic propagation of tau in the context of Alzheimer\u2019s disease.","volume":"15","author":"Fleeman","year":"2021","journal-title":"Front. Cell Neurosci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1523\/JNEUROSCI.0081-05.2005","article-title":"Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration.","volume":"25","author":"Forman","year":"2005","journal-title":"J. Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00401-023-02604-x","article-title":"Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy.","volume":"146","author":"Forrest","year":"2023","journal-title":"Acta Neuropathol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","article-title":"Alzheimer\u2019s disease associated with Down syndrome: A genetic form of dementia.","volume":"20","author":"Fortea","year":"2021","journal-title":"Lancet Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"170228","DOI":"10.1098\/rsob.170228","article-title":"The role of astrocytes in amyloid production and Alzheimer\u2019s disease.","volume":"7","author":"Frost","year":"2017","journal-title":"Open Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e14200","DOI":"10.1371\/journal.pone.0014200","article-title":"A role for thrombospondin-1 deficits in astrocyte-mediated spine and synaptic pathology in Down\u2019s syndrome.","volume":"5","author":"Garcia","year":"2010","journal-title":"PLoS One"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e106572","DOI":"10.1371\/journal.pone.0106572","article-title":"Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome.","volume":"9","author":"Garc\u00eda-Cerro","year":"2014","journal-title":"PLoS One"},{"key":"B88","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.nbd.2017.12.002","article-title":"Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene.","volume":"110","author":"Garc\u00eda-Cerro","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration.","volume":"4","author":"Gendron","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"B90","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.1523\/JNEUROSCI.1470-16.2016","article-title":"Phosphorylation of synaptojanin differentially regulates endocytosis of functionally distinct synaptic vesicle pools.","volume":"36","author":"Geng","year":"2016","journal-title":"J. Neurosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-024-00703-1","article-title":"Brain clearance of protein aggregates: A close-up on astrocytes.","volume":"19","author":"Giusti","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1138577","DOI":"10.3389\/fnsyn.2023.1138577","article-title":"Calcium signaling in astrocytes and gliotransmitter release.","volume":"15","author":"Goenaga","year":"2023","journal-title":"Front. Synaptic Neurosci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12974-019-1450-3","article-title":"Urolithin A attenuates memory impairment and neuroinflammation in APP\/PS1 mice.","volume":"16","author":"Gong","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1038\/s41593-024-01740-1","article-title":"Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress.","volume":"27","author":"Goodman","year":"2024","journal-title":"Nat. Neurosci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fncel.2014.00331","article-title":"DYRK1A-mediated phosphorylation of GluN2A at Ser(1048) regulates the surface expression and channel activity of GluN1\/GluN2A receptors.","volume":"8","author":"Grau","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/cvr\/cvr023","article-title":"Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.","volume":"90","author":"Grebe","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2012.01.007","article-title":"DYRK1A: A master regulatory protein controlling brain growth.","volume":"46","author":"Guedj","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.molmed.2006.12.005","article-title":"The tripartite synapse: Roles for gliotransmission in health and disease.","volume":"13","author":"Halassa","year":"2007","journal-title":"Trends Mol. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"42991","DOI":"10.1038\/srep42991","article-title":"Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein.","volume":"7","author":"Hallmann","year":"2017","journal-title":"Sci. Rep."},{"key":"B100","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0165-0270(02)00278-9","article-title":"A method for pulse and chase BrdU-labeling of early chick embryos.","volume":"122","author":"H\u00e4mmerle","year":"2002","journal-title":"J. Neurosci. Methods"},{"key":"B101","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1385\/NMM:3:3:173","article-title":"Alzheimer\u2019s amyloid beta-peptide enhances ATP\/gap junction-mediated calcium-wave propagation in astrocytes.","volume":"3","author":"Haughey","year":"2003","journal-title":"Neuromol. Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1742-2094-2-22","article-title":"Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice.","volume":"2","author":"Heneka","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"B103","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/(sici)1098-1136(199908)27:2<181::aid-glia8>3.0.co;2-9","article-title":"Cultured glial cells express the SNAP-25 analogue SNAP-23.","volume":"27","author":"Hepp","year":"1999","journal-title":"Glia"},{"key":"B104","doi-asserted-by":"publisher","first-page":"7231","DOI":"10.1523\/JNEUROSCI.1709-08.2008","article-title":"STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury.","volume":"28","author":"Herrmann","year":"2008","journal-title":"J. Neurosci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1042\/0264-6021:3590497","article-title":"Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A.","volume":"359","author":"Himpel","year":"2001","journal-title":"Biochem. J."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3791\/65029","article-title":"Assessment of chemical toxicity in adult drosophila melanogaster.","volume":"193","author":"Holsopple","year":"2023","journal-title":"J. Vis. Exp."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e70299","DOI":"10.1002\/mco2.70299","article-title":"Astrocyte in neurological disease: Pathogenesis and therapy.","volume":"6","author":"Huang","year":"2025","journal-title":"MedComm"},{"key":"B108","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer\u2019s disease.","volume":"45","author":"Hynd","year":"2004","journal-title":"Neurochem. Int."},{"key":"B109","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jnc.13164","article-title":"Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.","volume":"134","author":"Im","year":"2015","journal-title":"J. Neurochem."},{"key":"B110","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0896-6273(00)80747-3","article-title":"Making new connections: Role of ERK\/MAP kinase signaling in neuronal plasticity.","volume":"23","author":"Impey","year":"1999","journal-title":"Neuron"},{"key":"B111","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00294505","article-title":"Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics.","volume":"88","author":"Iwatsubo","year":"1994","journal-title":"Acta Neuropathol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40478-024-01844-6","article-title":"Astrocyte tau deposition in progressive supranuclear palsy is associated with dysregulation of MAPT transcription.","volume":"12","author":"Jackson","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"B113","doi-asserted-by":"publisher","first-page":"9791","DOI":"10.1021\/acs.jmedchem.8b00185","article-title":"Dual-Specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors as potential therapeutics.","volume":"61","author":"Jarhad","year":"2018","journal-title":"J. Med. Chem."},{"key":"B114","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.semcdb.2021.01.005","article-title":"GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer\u2019s disease.","volume":"116","author":"Jim\u00e9nez-Balado","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"15219","DOI":"10.1074\/jbc.M115.645507","article-title":"Truncation and activation of dual specificity tyrosine phosphorylation-regulated kinase 1A by Calpain I: A molecular mechanism linked to tau pathology in Alzheimer disease.","volume":"290","author":"Jin","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B116","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000334759","article-title":"A pilot study examining associations between DYRK1A and \u03b1-synuclein dementias.","volume":"10","author":"Jones","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1038\/nprot.2006.356","article-title":"Culturing hippocampal neurons.","volume":"1","author":"Kaech","year":"2006","journal-title":"Nat. Protoc."},{"key":"B118","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jnr.20534","article-title":"Regulation of the proapoptotic activity of huntingtin interacting protein 1 by Dyrk1 and caspase-3 in hippocampal neuroprogenitor cells.","volume":"81","author":"Kang","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1248\/bpb.b16-00825","article-title":"Neprilysin is suppressed by dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) in down-syndrome-derived fibroblasts.","volume":"40","author":"Kawakubo","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"B120","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s42003-021-02242-7","article-title":"A human isogenic iPSC-derived cell line panel identifies major regulators of aberrant astrocyte proliferation in Down syndrome.","volume":"4","author":"Kawatani","year":"2021","journal-title":"Commun. Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1091\/mbc.e04-12-1085","article-title":"DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras. B-Raf, and MEK1.","volume":"16","author":"Kelly","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"B122","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroscience.2011.08.028","article-title":"Form of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A nonphosphorylated at tyrosine 145 and 147 is enriched in the nuclei of astroglial cells, adult hippocampal progenitors, and some cholinergic axon terminals.","volume":"195","author":"Kida","year":"2011","journal-title":"Neuroscience"},{"key":"B123","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroscience.2017.02.011","article-title":"Astrocyte transport of glutamate and neuronal activity reciprocally modulate tau pathology in Drosophila.","volume":"348","author":"Kilian","year":"2017","journal-title":"Neuroscience"},{"key":"B124","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.bbrc.2004.08.102","article-title":"Regulation of Dyrk1A kinase activity by 14-3-3.","volume":"323","author":"Kim","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B125","doi-asserted-by":"publisher","first-page":"33250","DOI":"10.1074\/jbc.M606147200","article-title":"Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation.","volume":"281","author":"Kim","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B126","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/antiox8050121","article-title":"The role of astrocytes in the central nervous system focused on BK channel and heme oxygenase metabolites: A review.","volume":"8","author":"Kim","year":"2019","journal-title":"Antioxidants"},{"key":"B127","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000321994","article-title":"Overexpression of Dyrk1A causes the defects in synaptic vesicle endocytosis.","volume":"18","author":"Kim","year":"2010","journal-title":"Neurosignals"},{"key":"B128","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/hmg\/ddl437","article-title":"The DYRK1A gene, encoded in chromosome 21 down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.","volume":"16","author":"Kimura","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"B129","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides.","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat. Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1750-3639.1999.tb00549.x","article-title":"Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick\u2019s disease.","volume":"9","author":"Komori","year":"1999","journal-title":"Brain Pathol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/syn.20693","article-title":"Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats.","volume":"63","author":"Konradsson-Geuken","year":"2009","journal-title":"Synapse"},{"key":"B132","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/B978-0-12-802395-2.00025-0","article-title":"Tauopathies.","volume":"145","author":"Kovacs","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fnagi.2020.00096","article-title":"Astroglia and Tau: New perspectives.","volume":"12","author":"Kovacs","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B134","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","article-title":"Aging-related tau astrogliopathy (ARTAG): Harmonized evaluation strategy.","volume":"131","author":"Kovacs","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-018-0552-y","article-title":"Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain.","volume":"6","author":"Kovacs","year":"","journal-title":"Acta Neuropathol. Commun."},{"key":"B136","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/nan.12427","article-title":"Connexin-43 and aquaporin-4 are markers of ageing-related tau astrogliopathy (ARTAG)-related astroglial response.","volume":"44","author":"Kovacs","year":"","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1126\/science.1169096","article-title":"Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice.","volume":"323","author":"Kuchibhotla","year":"2009","journal-title":"Science"},{"key":"B138","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jnc.15565","article-title":"Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer\u2019s disease.","volume":"164","author":"Kumar","year":"2023","journal-title":"J. Neurochem."},{"key":"B139","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A review on Alzheimer\u2019s disease pathophysiology and its management: An update.","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.15252\/embr.201540374","article-title":"DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.","volume":"16","author":"Kurabayashi","year":"2015","journal-title":"EMBO Rep."},{"key":"B141","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1002\/alz.13779","article-title":"Age of Alzheimer\u2019s disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium.","volume":"20","author":"Larsen","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B142","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","article-title":"Roles of neuropathology-associated reactive astrocytes: A systematic review.","volume":"11","author":"Lawrence","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"B143","doi-asserted-by":"publisher","first-page":"106725","DOI":"10.1016\/j.phrs.2023.106725","article-title":"Inhibition of CDK4\/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A\/STAT3 signaling.","volume":"190","author":"Lee","year":"2023","journal-title":"Pharmacol. Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.freeradbiomed.2020.08.030","article-title":"The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation.","volume":"160","author":"Lee","year":"2020","journal-title":"Free Radic Biol. Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3945\/jn.109.109785","article-title":"Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice.","volume":"139","author":"Lee","year":"2009","journal-title":"J. Nutr."},{"key":"B146","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/life15020149","article-title":"DYRK1A up-regulation specifically impairs a presynaptic form of long-term potentiation.","volume":"15","author":"Lepagnol-Bestel","year":"2025","journal-title":"Life"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/hmg\/ddp047","article-title":"DYRK1A interacts with the REST\/NRSF-SWI\/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome.","volume":"18","author":"Lepagnol-Bestel","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"B148","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.biopsych.2021.01.012","article-title":"Dyrk1a mutations cause undergrowth of cortical pyramidal neurons via dysregulated growth factor signaling.","volume":"90","author":"Levy","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"B149","doi-asserted-by":"publisher","first-page":"47052","DOI":"10.1074\/jbc.M205374200","article-title":"DYRK3 activation, engagement of protein kinase A\/cAMP response element-binding protein, and modulation of progenitor cell survival.","volume":"277","author":"Li","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B150","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/00005072-199708000-00008","article-title":"Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression.","volume":"56","author":"Li","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.neuropharm.2010.10.016","article-title":"Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression.","volume":"60","author":"Li","year":"2011","journal-title":"Neuropharmacology"},{"key":"B152","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: Production. function, and therapeutic potential.","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"B153","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrn3192","article-title":"Mechanisms of CaMKII action in long-term potentiation.","volume":"13","author":"Lisman","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1096\/fj.07-104539","article-title":"Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome.","volume":"22","author":"Liu","year":"2008","journal-title":"FASEB J."},{"key":"B155","doi-asserted-by":"publisher","first-page":"109525","DOI":"10.1016\/j.neuropharm.2023.109525","article-title":"An inhibitor with GSK3\u03b2 and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer\u2019s disease.","volume":"232","author":"Liu","year":"2023","journal-title":"Neuropharmacology"},{"key":"B156","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.cell.2005.03.034","article-title":"Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs.","volume":"121","author":"Lochhead","year":"2005","journal-title":"Cell"},{"key":"B157","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbd.2019.01.017","article-title":"Neuronal overexpression of Alzheimer\u2019s disease and Down\u2019s syndrome associated DYRK1A\/minibrain gene alters motor decline, neurodegeneration and synaptic plasticity in Drosophila.","volume":"125","author":"Lowe","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"10755","DOI":"10.1074\/jbc.M110.174540","article-title":"REST regulates DYRK1A transcription in a negative feedback loop.","volume":"286","author":"Lu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B159","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2199-9-30","article-title":"Characterization of the human DYRK1A promoter and its regulation by the transcription factor E2F1.","volume":"9","author":"Maenz","year":"2008","journal-title":"BMC Mol. Biol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells8020184","article-title":"Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release.","volume":"8","author":"Mahmoud","year":"2019","journal-title":"Cells"},{"key":"B161","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/(sici)1098-1136(199905)26:3<233::aid-glia5>3.0.co;2-2","article-title":"A plethora of presynaptic proteins associated with ATP-storing organelles in cultured astrocytes.","volume":"26","author":"Maienschein","year":"1999","journal-title":"Glia"},{"key":"B162","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuint.2007.06.005","article-title":"Mechanisms of glutamate release from astrocytes.","volume":"52","author":"Malarkey","year":"2008","journal-title":"Neurochem. Int."},{"key":"B163","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.3390\/ijms20225671","article-title":"Excitatory amino acid transporters in physiology and disorders of the central nervous system.","volume":"20","author":"Malik","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1101\/2023.03.09.531874","article-title":"Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A.","author":"Manubens-Gil","year":"2023","journal-title":"bioRxiv [Preprint]"},{"key":"B165","doi-asserted-by":"publisher","first-page":"9122","DOI":"10.1523\/JNEUROSCI.0040-08.2008","article-title":"Fast subplasma membrane Ca2+ transients control exo-endocytosis of synaptic-like microvesicles in astrocytes.","volume":"28","author":"Marchaland","year":"2008","journal-title":"J. Neurosci."},{"key":"B166","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/s0006-8993(02)04069-6","article-title":"Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system.","volume":"964","author":"Mart\u00ed","year":"2003","journal-title":"Brain Res."},{"key":"B167","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/cercor\/bhr362","article-title":"Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons.","volume":"22","author":"Martinez de Lagran","year":"2012","journal-title":"Cereb. Cortex"},{"key":"B168","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1601-183X.2006.00285.x","article-title":"Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+\/-).","volume":"6","author":"Martinez de Lagran","year":"2007","journal-title":"Genes Brain Behav."},{"key":"B169","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.3390\/ijms21186906","article-title":"Signalling pathways implicated in Alzheimer\u2019s disease neurodegeneration in individuals with and without down syndrome.","volume":"21","author":"Mart\u00ednez-Cu\u00e9","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1742-2094-10-90","article-title":"\u0142H-deprenyl and \u0142H-PIB autoradiography show different laminar distributions of astroglia and fibrillar \u03b2-amyloid in Alzheimer brain.","volume":"10","author":"Marutle","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"B171","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/molecules23020064","article-title":"Indole-3-Carbonitriles as DYRK1A inhibitors by fragment-based drug design.","volume":"23","author":"Meine","year":"2018","journal-title":"Molecules"},{"key":"B172","doi-asserted-by":"publisher","first-page":"e13000","DOI":"10.1111\/acel.13000","article-title":"Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer\u2019s disease.","volume":"18","author":"Melchior","year":"2019","journal-title":"Aging Cell"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/biom11091367","article-title":"Exocytosis in astrocytes.","volume":"11","author":"Mielnicka","year":"2021","journal-title":"Biomolecules"},{"key":"B174","doi-asserted-by":"publisher","first-page":"e202302129","DOI":"10.26508\/lsa.202302129","article-title":"Identification of FAM53C as a cytosolic-anchoring inhibitory binding protein of the kinase DYRK1A.","volume":"6","author":"Miyata","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"B175","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.celrep.2018.06.033","article-title":"Aberrant calcium signaling in astrocytes inhibits neuronal excitability in a human down syndrome stem cell model.","volume":"24","author":"Mizuno","year":"2018","journal-title":"Cell Rep."},{"key":"B176","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1523\/JNEUROSCI.3770-03.2004","article-title":"Vesicular glutamate transporter-dependent glutamate release from astrocytes.","volume":"24","author":"Montana","year":"2004","journal-title":"J. Neurosci."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/biomedicines10061380","article-title":"DYRK1A and activity-dependent neuroprotective protein comparative diagnosis interest in cerebrospinal fluid and plasma in the context of Alzheimer-Related cognitive impairment in down syndrome patients.","volume":"10","author":"Moreau","year":"2022","journal-title":"Biomedicines"},{"key":"B178","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrm3284","article-title":"Septins: The fourth component of the cytoskeleton.","volume":"13","author":"Mostowy","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"e34845","DOI":"10.1371\/journal.pone.0034845","article-title":"Phosphorylation by Dyrk1A of clathrin coated vesicle-associated proteins: Identification of the substrate proteins and the effects of phosphorylation.","volume":"7","author":"Murakami","year":"2012","journal-title":"PLoS One"},{"key":"B180","doi-asserted-by":"publisher","first-page":"9297","DOI":"10.1021\/bi9010557","article-title":"Dyrk1A binds to multiple endocytic proteins required for formation of clathrin-coated vesicles.","volume":"48","author":"Murakami","year":"2009","journal-title":"Biochemistry"},{"key":"B181","doi-asserted-by":"publisher","first-page":"23712","DOI":"10.1074\/jbc.M513497200","article-title":"Phosphorylation of amphiphysin I by minibrain kinase\/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome.","volume":"281","author":"Murakami","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B182","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/BF00296783","article-title":"Paired helical filaments in astrocytes: Electron microscopy and immunohistochemistry in a case of atypical Alzheimer\u2019s disease.","volume":"83","author":"Nakano","year":"1992","journal-title":"Acta Neuropathol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"dmm035634","DOI":"10.1242\/dmm.035634","article-title":"Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A.","volume":"11","author":"Nguyen","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/jnen\/nlz094","article-title":"Astrocytic tau deposition is frequent in typical and atypical Alzheimer disease presentations.","volume":"78","author":"Nolan","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.neuron.2016.03.027","article-title":"Phosphorylation of \u03b2-Tubulin by the down syndrome kinase, Minibrain\/DYRK1a, regulates microtubule dynamics and dendrite morphogenesis.","volume":"90","author":"Ori-McKenney","year":"2016","journal-title":"Neuron"},{"key":"B186","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12974-024-03117-4","article-title":"Overexpression of pathogenic tau in astrocytes causes a reduction in AQP4 and GLT1, an immunosuppressed phenotype and unique transcriptional responses to repetitive mild TBI without appreciable changes in tauopathy.","volume":"21","author":"Ortiz","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"B187","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pneurobio.2016.01.001","article-title":"Astrogliosis: An integral player in the pathogenesis of Alzheimer\u2019s disease.","volume":"144","author":"Osborn","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/glia.24291","article-title":"Glial progenitor cells of the adult human white and grey matter are contextually distinct.","volume":"71","author":"Osorio","year":"2023","journal-title":"Glia"},{"key":"B189","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40659-023-00422-9","article-title":"DYRK1-mediated phosphorylation of endocytic components is required for extracellular lumen expansion in ascidian notochord.","volume":"56","author":"Ouyang","year":"2023","journal-title":"Biol. Res."},{"key":"B190","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1074\/jbc.M110.157909","article-title":"Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activity.","volume":"286","author":"Papadopoulos","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/j.1471-4159.2012.07861.x","article-title":"Phosphorylation of Munc18-1 by Dyrk1A regulates its interaction with Syntaxin 1 and X11\u03b1.","volume":"122","author":"Park","year":"2012","journal-title":"J. Neurochem."},{"key":"B192","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1007\/s00018-009-0123-2","article-title":"Function and regulation of Dyrk1A: Towards understanding Down syndrome.","volume":"66","author":"Park","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"B193","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1242\/jcs.086124","article-title":"Dyrk1A negatively regulates the actin cytoskeleton through threonine phosphorylation of N-WASP.","volume":"125","author":"Park","year":"2012","journal-title":"J. Cell Sci."},{"key":"B194","doi-asserted-by":"publisher","first-page":"8629","DOI":"10.1073\/pnas.97.15.8629","article-title":"Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons.","volume":"97","author":"Parpura","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B195","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","article-title":"Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration.","volume":"19","author":"Patani","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/brain\/awab281","article-title":"Astrocyte-neuron interplay is critical for Alzheimer\u2019s disease pathogenesis and is rescued by TRPA1 channel blockade.","volume":"145","author":"Paumier","year":"2022","journal-title":"Brain"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/physrev.00041.2013","article-title":"Astrocyte reactivity and reactive astrogliosis: Costs and benefits.","volume":"94","author":"Pekny","year":"2014","journal-title":"Physiol. Rev."},{"key":"B198","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40478-021-01146-1","article-title":"Astrocytes respond to a neurotoxic A\u03b2 fragment with state-dependent Ca2+ alteration and multiphasic transmitter release.","volume":"9","author":"Pham","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"B199","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0306-4522(94)90547-9","article-title":"Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer\u2019s disease.","volume":"63","author":"Pike","year":"1994","journal-title":"Neuroscience"},{"key":"B200","doi-asserted-by":"publisher","first-page":"e81828","DOI":"10.1371\/journal.pone.0081828","article-title":"\u03b17 Nicotinic receptor-mediated astrocytic gliotransmitter release: A\u03b2 effects in a preclinical Alzheimer\u2019s mouse model.","volume":"8","author":"Pirttimaki","year":"2013","journal-title":"PLoS One"},{"key":"B201","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/hmg\/ddaa003","article-title":"Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics.","volume":"29","author":"Ponroy Bally","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"B202","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1021\/acsmedchemlett.1c00630","article-title":"Selective macrocyclic inhibitors of DYRK1A\/B.","volume":"13","author":"Powell","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"B203","doi-asserted-by":"publisher","first-page":"101335","DOI":"10.1016\/j.arr.2021.101335","article-title":"Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer\u2019s disease.","volume":"68","author":"Price","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"B204","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1038\/s41380-023-02061-8","article-title":"Revisiting the critical roles of reactive astrocytes in neurodegeneration.","volume":"28","author":"Qian","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"B205","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3233\/JAD-130824","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) enhances tau expression.","volume":"37","author":"Qian","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B206","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1172\/JCI89354","article-title":"Astrocytic calcium release mediates peri-infarct depolarizations in a rodent stroke model.","volume":"127","author":"Rakers","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B207","doi-asserted-by":"publisher","first-page":"e870","DOI":"10.1002\/cpz1.870","article-title":"Perspectives on the Drosophila melanogaster model for advances in toxicological science.","volume":"3","author":"Rand","year":"2023","journal-title":"Curr. Protoc."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1084\/jem.20171487","article-title":"P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer\u2019s disease model.","volume":"215","author":"Reichenbach","year":"2018","journal-title":"J. Exp. Med."},{"key":"B209","doi-asserted-by":"publisher","first-page":"e9665","DOI":"10.15252\/emmm.201809665","article-title":"Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer\u2019s disease model.","volume":"11","author":"Reichenbach","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"B210","doi-asserted-by":"publisher","first-page":"572850","DOI":"10.3389\/fneur.2020.572850","article-title":"Astrocytes in tauopathies.","volume":"11","author":"Reid","year":"2020","journal-title":"Front. Neurol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41593-020-00728-x","article-title":"Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer\u2019s disease.","volume":"23","author":"Richetin","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B212","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neurobiolaging.2023.04.010","article-title":"Atrophic astrocytes in aged marmosets present tau hyperphosphorylation, RNA oxidation, and DNA fragmentation.","volume":"129","author":"Rodr\u00edguez-Callejas","year":"2023","journal-title":"Neurobiol. Aging"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00259-015-3047-0","article-title":"Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: A correlative positron emission tomography and in vitro imaging study.","volume":"42","author":"Rodriguez-Vieitez","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"B214","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/brain\/awv404","article-title":"Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer\u2019s disease.","volume":"139","author":"Rodriguez-Vieitez","year":"2016","journal-title":"Brain"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.celrep.2018.04.008","article-title":"DYRK1A kinase positively regulates angiogenic responses in endothelial cells.","volume":"23","author":"Rozen","year":"2018","journal-title":"Cell Rep."},{"key":"B216","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1523\/JNEUROSCI.2517-15.2016","article-title":"Overexpression of Dyrk1A, a down syndrome candidate, decreases excitability and impairs gamma oscillations in the prefrontal cortex.","volume":"36","author":"Ruiz-Mejias","year":"2016","journal-title":"J. Neurosci."},{"key":"B217","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1471-4159.2007.05075.x","article-title":"Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: Evidence for a functional link between Down syndrome and Alzheimer\u2019s disease.","volume":"104","author":"Ryoo","year":"2008","journal-title":"J. Neurochem."},{"key":"B218","doi-asserted-by":"publisher","first-page":"34850","DOI":"10.1074\/jbc.M707358200","article-title":"DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease.","volume":"282","author":"Ryoo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B219","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1471-4159.2010.06769.x","article-title":"Dyrk1A-mediated phosphorylation of Presenilin 1: A functional link between Down syndrome and Alzheimer\u2019s disease.","volume":"115","author":"Ryu","year":"2010","journal-title":"J. Neurochem."},{"key":"B220","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1756-6606-3-40","article-title":"The physiological roles of vesicular GABA transporter during embryonic development: A study using knockout mice.","volume":"3","author":"Saito","year":"2010","journal-title":"Mol. Brain"},{"key":"B221","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00401-006-0093-5","article-title":"Corticobasal degeneration with focal, massive tau accumulation in the subcortical white matter astrocytes.","volume":"112","author":"Sakai","year":"2006","journal-title":"Acta Neuropathol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"12040","DOI":"10.1038\/s41598-021-90545-4","article-title":"Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model.","volume":"11","author":"Saleh","year":"2021","journal-title":"Sci. Rep."},{"key":"B223","first-page":"322","article-title":"The role of excitotoxicity in neurodegeneration.","volume":"43","author":"Sali\u00f1ska","year":"2005","journal-title":"Folia Neuropathol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1242\/jcs.040162","article-title":"Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons.","volume":"122","author":"Scales","year":"2009","journal-title":"J. Cell Sci."},{"key":"B225","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1038\/ncomms9023","article-title":"Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1.","volume":"6","author":"Schneider","year":"2015","journal-title":"Nat. Commun."},{"key":"B226","doi-asserted-by":"publisher","first-page":"16404","DOI":"10.1038\/srep16404","article-title":"Early astrocytosis in autosomal dominant Alzheimer\u2019s disease measured in vivo by multi-tracer positron emission tomography.","volume":"5","author":"Sch\u00f6ll","year":"2015","journal-title":"Sci. Rep."},{"key":"B227","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/febs.13249","article-title":"Parkin structure and function.","volume":"282","author":"Seirafi","year":"2015","journal-title":"FEBS J."},{"key":"B228","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1073\/pnas.071540198","article-title":"Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores.","volume":"98","author":"Sharma","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B229","doi-asserted-by":"publisher","first-page":"8372","DOI":"10.1038\/ncomms9372","article-title":"Inhibition of DYRK1A and GSK3B induces human \u03b2-cell proliferation.","volume":"6","author":"Shen","year":"2015","journal-title":"Nat. Commun."},{"key":"B230","doi-asserted-by":"publisher","first-page":"28660","DOI":"10.1074\/jbc.M802645200","article-title":"Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome.","volume":"283","author":"Shi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B231","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/1097-4547(20000715)61:2<146::AID-JNR5>3.0.CO;2-C","article-title":"Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion.","volume":"61","author":"Shields","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"B232","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1073\/pnas.95.10.5768","article-title":"Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis.","volume":"95","author":"Shields","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B233","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1016\/j.neuron.2023.09.009","article-title":"An inhibitory circuit-based enhancer of DYRK1A function reverses Dyrk1a-associated impairment in social recognition.","volume":"111","author":"Shih","year":"2023","journal-title":"Neuron"},{"key":"B234","first-page":"693","article-title":"Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer\u2019s disease brain tissues.","volume":"64","author":"Shin","year":"1991","journal-title":"Lab Invest."},{"key":"B235","doi-asserted-by":"publisher","first-page":"1078987","DOI":"10.3389\/fmolb.2022.1078987","article-title":"Disruption of DYRK1A-induced hyperphosphorylation of amyloid-beta and tau protein in Alzheimer\u2019s disease: An integrative molecular modeling approach.","volume":"9","author":"Shukla","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"B236","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.neuroscience.2008.09.034","article-title":"The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4.","volume":"157","author":"Sitz","year":"2008","journal-title":"Neuroscience"},{"key":"B237","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.it.2020.07.004","article-title":"Astrocyte reactivity: Subtypes, States, and functions in CNS innate immunity.","volume":"41","author":"Sofroniew","year":"2020","journal-title":"Trends Immunol."},{"key":"B238","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: Biology and pathology.","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12974-018-1134-4","article-title":"The A\u03b2 protofibril selective antibody mAb158 prevents accumulation of A\u03b2 in astrocytes and rescues neurons from A\u03b2-induced cell death.","volume":"15","author":"S\u00f6llvander","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"B240","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1523\/JNEUROSCI.0877-17.2017","article-title":"Calcineurin\/NFAT signaling in activated astrocytes drives network hyperexcitability in A\u03b2-Bearing mice.","volume":"37","author":"Sompol","year":"2017","journal-title":"J. Neurosci."},{"key":"B241","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.4161\/cc.29104","article-title":"The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation.","volume":"13","author":"Soppa","year":"2014","journal-title":"Cell Cycle"},{"key":"B242","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-019-0678-6","article-title":"Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP\/PS1 mice.","volume":"7","author":"Souchet","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"B243","doi-asserted-by":"publisher","first-page":"480","DOI":"10.14283\/jpad.2022.18","article-title":"Cerebral Phospho-Tau acts synergistically with soluble A\u03b242 leading to mild cognitive impairment in AAV-AD rats.","volume":"9","author":"Souchet","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B244","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nbd.2014.04.016","article-title":"Excitation\/inhibition balance and learning are modified by Dyrk1a gene dosage.","volume":"69","author":"Souchet","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B245","doi-asserted-by":"publisher","first-page":"903729","DOI":"10.3389\/fncel.2022.903729","article-title":"The challenging pathway of treatment for neurogenesis impairment in down syndrome: Achievements and perspectives.","volume":"16","author":"Stagni","year":"2022","journal-title":"Front. Cell Neurosci."},{"key":"B246","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-Synuclein in Parkinson\u2019s disease.","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B247","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/09687680701790925","article-title":"EAAT2 density at the astrocyte plasma membrane and Ca(2 +)-regulated exocytosis.","volume":"25","author":"Stenovec","year":"2008","journal-title":"Mol. Membr. Biol."},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-025-01565-w","article-title":"A novel feedback loop between DYRK2 and USP28 regulates cancer homeostasis and DNA damage signaling.","author":"Suanes-Cobos","year":"2025","journal-title":"Cell Death Differ."},{"key":"B249","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fphar.2015.00221","article-title":"\u03b2-Amyloid: The key peptide in the pathogenesis of Alzheimer\u2019s disease.","volume":"6","author":"Sun","year":"2015","journal-title":"Front. Pharmacol."},{"key":"B250","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1196\/annals.1379.004","article-title":"Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer\u2019s disease.","volume":"1097","author":"Takano","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B251","doi-asserted-by":"publisher","first-page":"E2518","DOI":"10.1073\/pnas.1306832110","article-title":"A\u03b2 induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.","volume":"110","author":"Talantova","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B252","doi-asserted-by":"publisher","first-page":"e13000","DOI":"10.1111\/nan.13000","article-title":"Ageing-related tau astrogliopathy severely affecting the substantia nigra.","volume":"50","author":"Tanaka","year":"2024","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B253","doi-asserted-by":"publisher","first-page":"100233","DOI":"10.1074\/jbc.REV120.015217","article-title":"Emerging roles of DYRK2 in cancer.","volume":"296","author":"Tandon","year":"2021","journal-title":"J. Biol. Chem."},{"key":"B254","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1523\/JNEUROSCI.2852-13.2014","article-title":"Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a.","volume":"34","author":"Thomazeau","year":"2014","journal-title":"J. Neurosci."},{"key":"B255","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1002\/jcb.27639","article-title":"miRNA profiling in the hippocampus of attention-deficit\/hyperactivity disorder rats.","volume":"120","author":"Tian","year":"2019","journal-title":"J. Cell Biochem."},{"key":"B256","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.freeradbiomed.2017.09.025","article-title":"Dendritic spine pathology and thrombospondin-1 deficits in Down syndrome.","volume":"114","author":"Torres","year":"2018","journal-title":"Free Radic Biol. Med."},{"key":"B257","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.3390\/ijms21165858","article-title":"Revisiting the amyloid cascade hypothesis: From Anti-a\u03b2 therapeutics to auspicious new ways for Alzheimer\u2019s disease.","volume":"21","author":"Uddin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B258","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.1523\/JNEUROSCI.4365-14.2015","article-title":"Differential regulation of two isoforms of the glial glutamate transporter EAAT2 by DLG1 and CaMKII.","volume":"35","author":"Underhill","year":"2015","journal-title":"J. Neurosci."},{"key":"B259","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2613.2000.00169.x","article-title":"The pathogenic activation of calpain: A marker and mediator of cellular toxicity and disease states.","volume":"81","author":"Vanderklish","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1007\/s11064-015-1545-x","article-title":"Excitable astrocytes: Ca(2+)- and cAMP-regulated exocytosis.","volume":"40","author":"Vardjan","year":"2015","journal-title":"Neurochem. Res."},{"key":"B261","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-023-01628-9","article-title":"Astrocytes in human central nervous system diseases: A frontier for new therapies.","volume":"8","author":"Verkhratsky","year":"2023","journal-title":"Signal Transduct Target Ther."},{"key":"B262","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1111\/febs.12411","article-title":"Mechanism of dual specificity kinase activity of DYRK1A.","volume":"280","author":"Walte","year":"2013","journal-title":"FEBS J."},{"key":"B263","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1038\/s41598-017-07655-1","article-title":"Dual-specificity tyrosine-phosphorylation regulated kinase 1A gene transcription is regulated by myocyte enhancer factor 2D.","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"B264","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12035-008-8039-7","article-title":"Regulation of synaptic transmission by presynaptic CaMKII and BK channels.","volume":"38","author":"Wang","year":"2008","journal-title":"Mol. Neurobiol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00401-008-0419-6","article-title":"The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.","volume":"116","author":"Wegiel","year":"2008","journal-title":"Acta Neuropathol."},{"key":"B266","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1742-4658.2010.07955.x","article-title":"The role of DYRK1A in neurodegenerative diseases.","volume":"278","author":"Wegiel","year":"","journal-title":"FEBS J."},{"key":"B267","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/NEN.0b013e318202bfa1","article-title":"Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome.","volume":"70","author":"Wegiel","year":"","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B268","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainres.2004.03.008","article-title":"Cell type- and brain structure-specific patterns of distribution of minibrain kinase in human brain.","volume":"1010","author":"Wegiel","year":"2004","journal-title":"Brain Res."},{"key":"B269","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00401-024-02823-w","article-title":"Single-cell transcriptomic and neuropathologic analysis reveals dysregulation of the integrated stress response in progressive supranuclear palsy.","volume":"148","author":"Whitney","year":"2023","journal-title":"Acta Neuropathol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/s0006-291x(03)00148-7","article-title":"Unusual function of the activation loop in the protein kinase DYRK1A.","volume":"302","author":"Wiechmann","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B271","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13024-020-00416-1","article-title":"Astrocyte-derived clusterin suppresses amyloid formation in vivo.","volume":"15","author":"Wojtas","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"B272","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41380-022-01454-5","article-title":"APP and DYRK1A regulate axonal and synaptic vesicle protein networks and mediate Alzheimer\u2019s pathology in trisomy 21 neurons.","volume":"27","author":"Wu","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"B273","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11064-019-02936-9","article-title":"Resveratrol Downregulates STAT3 expression and astrocyte activation in primary astrocyte cultures of rat.","volume":"45","author":"Wu","year":"2020","journal-title":"Neurochem. Res."},{"key":"B274","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nm838","article-title":"Adult mouse astrocytes degrade amyloid-beta in vitro and in situ.","volume":"9","author":"Wyss-Coray","year":"2003","journal-title":"Nat. Med."},{"key":"B275","doi-asserted-by":"publisher","first-page":"E1224","DOI":"10.1073\/pnas.1614893114","article-title":"DYRK1A regulates Hap1-Dcaf7\/WDR68 binding with implication for delayed growth in Down syndrome.","volume":"114","author":"Xiang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B276","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4711-09.2010","article-title":"Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells.","volume":"30","author":"Yabut","year":"2010","journal-title":"J. Neurosci."},{"key":"B277","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuroscience.2017.08.030","article-title":"Epigallocatechin gallate induces extracellular degradation of amyloid \u03b2-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways.","volume":"362","author":"Yamamoto","year":"2017","journal-title":"Neuroscience"},{"key":"B278","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41583-022-00624-2","article-title":"CaMKII: A central molecular organizer of synaptic plasticity, learning and memory.","volume":"23","author":"Yasuda","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"B279","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41598-017-00682-y","article-title":"Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice.","volume":"7","author":"Yin","year":"2017","journal-title":"Sci. Rep."},{"key":"B280","doi-asserted-by":"publisher","first-page":"8848642","DOI":"10.1155\/2023\/8848642","article-title":"Dyrk1a phosphorylation of \u03b1-Synuclein mediating apoptosis of dopaminergic neurons in Parkinson\u2019s disease.","volume":"2023","author":"Yong","year":"2023","journal-title":"Parkinsons. Dis."},{"key":"B281","doi-asserted-by":"publisher","first-page":"e0207779","DOI":"10.1371\/journal.pone.0207779","article-title":"DCAF7\/WDR68 is required for normal levels of DYRK1A and DYRK1B.","volume":"13","author":"Yousefelahiyeh","year":"2018","journal-title":"PLoS One"},{"key":"B282","doi-asserted-by":"publisher","first-page":"15847","DOI":"10.1038\/s41598-022-19967-y","article-title":"DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-\u03b2, Tau and DYRK1A neurotoxicity.","volume":"12","author":"Zhu","year":"2022","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1626062\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:14:30Z","timestamp":1760933670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1626062\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":282,"alternative-id":["10.3389\/fnins.2025.1626062"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1626062","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"article-number":"1626062"}}